Common Stock, Shares, Outstanding of Aurinia Pharmaceuticals Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Aurinia Pharmaceuticals Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Aurinia Pharmaceuticals Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 132,323,000, a 6.1% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Aurinia Pharmaceuticals Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 132,323,000 -8,560,000 -6.1% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 131,841,000 -11,268,000 -7.9% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 132,668,000 -10,316,000 -7.2% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 137,747,000 -5,943,000 -4.1% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 140,883,000 -2,950,000 -2.1% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 143,109,000 -496,000 -0.34% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 142,984,000 -385,000 -0.27% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 143,690,000 +661,000 +0.46% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 143,833,000 +1,565,000 +1.1% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 143,605,000 +1,495,000 +1.1% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 143,369,000 +1,477,000 +1% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 143,029,000 +1,287,000 +0.91% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 142,268,000 +668,000 +0.47% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 142,110,000 +12,540,000 +9.7% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 141,892,000 +13,496,000 +11% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 141,742,000 +13,621,000 +11% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 141,600,000 +14,900,000 +12% 31 Dec 2021 10-K 15 Feb 2024 2023 FY
Q3 2021 129,570,000 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 128,396,000 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 128,121,000 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 126,700,000 +14,900,000 +13% 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q4 2019 111,800,000 +26,300,000 +31% 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q4 2018 85,500,000 31 Dec 2018 10-K 24 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.